Assenagon Asset Management’s DarioHealth DRIO Stock Holding History

Assenagon Asset Management’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-913	Closed	-$85K	–	1380
2022 Q3	$85K	Sell	913 -237	-21%	-$25.4K	﹤0.01%	1299
2022 Q2	$141K	Buy	+1,150	New	+$135K	﹤0.01%	1401
2021 Q3	–	Sell	-1,575	Closed	-$673K	–	1323
2021 Q2	$673K	Buy	+1,575	New	+$600K	﹤0.01%	983

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Assenagon Asset Management's DRIO Position: Q4 2022 in Review

Assenagon Asset Management sold out of DarioHealth (DRIO) in Q4 2022, closing a stake of 913 shares — an estimated $85K sold.

Assenagon Asset Management first reported a position in DRIO in Q2 2021 and held it in 3 quarters. The position peaked at $673K in Q2 2021. 47 funds tracked by Wall St. Rank hold DRIO as of Q4 2022.

Assenagon Asset Management reported no remaining DarioHealth position as of Q4 2022 after selling out during the quarter.
Assenagon Asset Management sold 913 DarioHealth shares in Q4 2022, an estimated $85K.
Assenagon Asset Management first reported a position in DarioHealth in Q2 2021 and held it in 3 quarters.
Assenagon Asset Management's DarioHealth position peaked at $673K in Q2 2021.
47 funds tracked by Wall St. Rank held DarioHealth as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.